How to correct hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyponatremia with Sodium Level of 124 mmol/L

For a patient with hyponatremia (sodium 124 mmol/L), correction should be based on symptom severity, with a maximum increase of 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome. 1

Initial Assessment

  • Evaluate volume status and classify as hypovolemic, euvolemic, or hypervolemic hyponatremia to determine the underlying cause 1
  • Check urine osmolality and sodium concentration to distinguish between SIADH and other causes 1
  • Assess symptom severity (mild/asymptomatic vs. severe symptoms like seizures or coma) to guide correction rate 1

Treatment Based on Symptom Severity

For Severe Symptoms (seizures, coma)

  • Administer 3% hypertonic saline with an initial goal to correct 6 mmol/L over 6 hours or until severe symptoms resolve 1
  • Calculate sodium deficit using formula: Desired increase in Na (mEq/L) × (0.5 × ideal body weight in kg) 1
  • Monitor serum sodium every 2 hours during initial correction 1
  • Total correction should not exceed 8 mmol/L in 24 hours 1

For Mild/Asymptomatic Hyponatremia

  • Treatment depends on volume status and underlying cause 1
  • For euvolemic hyponatremia (SIADH): Implement fluid restriction to 1 L/day 1
  • For hypovolemic hyponatremia: Discontinue diuretics and administer isotonic saline (0.9% NaCl) for volume repletion 1
  • For hypervolemic hyponatremia (cirrhosis, heart failure): Implement fluid restriction to 1-1.5 L/day 1

Special Considerations

  • Patients with advanced liver disease, alcoholism, malnutrition, or prior encephalopathy require more cautious correction (4-6 mmol/L per day) due to higher risk of osmotic demyelination syndrome 1
  • Avoid fluid restriction in patients with cerebral salt wasting (CSW) as it can worsen outcomes 1
  • Tolvaptan should be initiated only in a hospital setting where serum sodium can be monitored closely 2
  • Too rapid correction of hyponatremia (>12 mEq/L/24 hours) can cause osmotic demyelination resulting in dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma, and death 2

Pharmacological Options

  • For SIADH resistant to fluid restriction, consider:

    • Oral sodium chloride supplements 1
    • Tolvaptan (vasopressin receptor antagonist) starting at 15 mg once daily, may increase to 30 mg after 24 hours if needed 2
    • Urea as an effective and safe alternative treatment 3
  • For hypervolemic hyponatremia in cirrhosis:

    • Consider albumin infusion alongside fluid restriction 1
    • Avoid hypertonic saline unless life-threatening symptoms are present 1

Monitoring and Follow-up

  • Monitor serum sodium levels frequently during correction 1
  • For severe symptoms: Check sodium every 2 hours initially 1
  • For mild/asymptomatic: Check sodium daily 1
  • Watch for signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically occurring 2-7 days after rapid correction 1
  • If overcorrection occurs, consider relowering with electrolyte-free water or desmopressin 1

Common Pitfalls to Avoid

  • Overly rapid correction exceeding 8 mmol/L in 24 hours leading to osmotic demyelination syndrome 1
  • Inadequate monitoring during active correction 1
  • Using fluid restriction in cerebral salt wasting 1
  • Failing to recognize and treat the underlying cause 1
  • Using hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms 1

References

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.